CareRx Corp: MDA EN
CareRx Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
CareRx Corporation Reports Q4 Adjusted EPS of $0.12, Far Above FactSet Est of $0.02
CareRx Corporation to Host Fourth Quarter 2024 Financial Results Conference Call on Wednesday, March 5, 2025 at 8:30 A.m. ET
CareRx Q3 Net Loss Narrows on Lower Finance Costs, Cost-Saving Moves
CareRx Corp (CHHHF) Q2 2024 Earnings Call Highlights: Operational Efficiency Boosts Adjusted ...
CareRx Brief: Consolidating Its Existing Burnaby and Vancouver Pharmacy Operations Into the New North Burnaby Location, Starting Early December 2024
CareRx Brief: Says Opening State-of-the-Art Pharmacy in British Columbia
Earnings Flash: CareRx Q2 Diluted EPS $0.13, Up From $0.11 in 2023
CareRx Corp. Is Maintained at Buy by Desjardins Securities
CareRx Corp. Price Target Raised to C$4.00/Share From C$3.75 by Desjardins Securities
CareRx Brief: Dalton Will Be Succeeded by Jeff Watson, a Current Independent Director of the Board
CareRx Brief: Company Undertaking a Search for a New CFO; Davide Pernarella, Currently Vice President, Business Planning and Analysis at CareRx, Will Assume the Role of Interim CFO
CareRx Brief: Says Andrew Mok Will Step Down as Chief Financial Officer Effective June 7, 2024, to Pursue Another Employment Opportunity
CareRx Q1 Net Loss Narrows, Revenue Dips
Calendar of Canada Earnings Expected in the Week Ahead
CareRx Corporation to Host First Quarter 2024 Financial Results Conference Call on Friday, May 10, 2024 at 8:30 A.m. ET
CareRX Corp. Is Maintained at Buy by Desjardins Securities
CareRx to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 17, 2024
CareRx Corporation Welcomes Ontario Government's Pause of Planned Fee Changes